Lopinavir/Ritonavir Induces the Hepatic Activity of Cytochrome P450 Enzymes CYP2C9, CYP2C19, and CYP1A2 But Inhibits the Hepatic and Intestinal Activity of CYP3A as Measured by a Phenotyping Drug Cocktail in Healthy Volunteers
Rosa F. Yeh(Seattle Cancer Care Alliance), Angela D. M. Kashuba(University of North Carolina at Chapel Hill), Michael Blake, Vincent E. Gaver(University of North Carolina at Chapel Hill), Faustina Baxter-Meheux(University of North Carolina at Chapel Hill), John Rublein(Abbott (United Kingdom)), Cheri E. Klein(Abbott (United Kingdom)), Naser L. Rezk(University of North Carolina at Chapel Hill), Kristine B. Patterson(University of North Carolina at Chapel Hill), Joseph J. Eron(University of North Carolina at Chapel Hill)
JAIDS Journal of Acquired Immune Deficiency Syndromes
April 25, 2006
Cited by 193
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2012|2.5k
Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
|New England Journal of Medicine|1997|1.9k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k